Načítá se...
Molecular landscape and targeted therapy of acute myeloid leukemia
For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by identifying...
Uloženo v:
| Vydáno v: | Biomark Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225571/ https://ncbi.nlm.nih.gov/pubmed/30455953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0146-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|